Physician profile
Aaron K Compton
NPI 1609918879
$2,798.51
in general payments reported to CMS, 2019-2025
18 companies · $289 in 2025
The $289 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $714 · 2021: $314 · 2022: $180 · 2023: $333 · 2024: $595 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,074 · Education: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,073.66 |
| Education | $143.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,688.44 | 2019-2025 | Proclaim, Octrode, Eterna |
| Nevro Corp. | $223.89 | 2019-2024 | Senza |
| Boston Scientific Corporation | $210.83 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Si-Bone, INC. | $174.44 | 2019-2024 | |
| Stryker Corporation | $124.85 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $72.38 | 2024-2025 | |
| Abbvie INC. | $51.11 | 2022 | |
| Horizon Therapeutics Plc | $45.39 | 2019-2023 | Krystexxa |
| Averitas Pharma INC. | $42.23 | 2023-2024 | Qutenza |
| Redhill Biopharma INC. | $29.12 | 2021 | |
| Radius Health, INC. | $26.48 | 2021 | |
| Scilex Pharmaceuticals INC. | $20.77 | 2024 | |
| Amgen INC. | $18.99 | 2019 | |
| Assertio Therapeutics, INC. | $15.95 | 2019 | |
| Baudax Bio INC. | $13.95 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $13.56 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.14 | 2019 | |
| Zyla Life Sciences, INC. | $12.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Compton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.